Navin Fluorine International Limited (NAVINFLUOR)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 1 August 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹7,567.5 ↑ 49.92% (1Y)

🎯 Key Takeaways

  • Navin Fluorine International is in a high-growth phase driven by strategic capacity expansion in specialty chemicals and HPP segments, supported by strong order visibility and margin improvement. The company is transitioning from a turnaround to a scalable growth trajectory, leveraging its vertically integrated model and pricing power amid raw material inflation.
  • Revenue grew 16.9% QoQ to ₹606 in Q3FY25.
  • ⚠️ Execution delays in the Chemours and HFC projects could impact FY27 capacity targets and margin trajectory.
Market Cap
₹35,894
P/E Ratio
131.5
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Navin Fluorine International is in a high-growth phase driven by strategic capacity expansion in specialty chemicals and HPP segments, supported by strong order visibility and margin improvement. The company is transitioning from a turnaround to a scalable growth trajectory, leveraging its vertically integrated model and pricing power amid raw material inflation.

📰 What's Happening

In Q4 FY26, management reported 34% YoY revenue growth and 124% PAT growth, fueled by 35%+ growth in Specialty Chemicals and 45%+ in HPP segments. The company commissioned 32 MPP HFC capacity and advanced the Chemours project, targeting completion by early July FY27. Capex updates and strong working capital (74 days) underscore execution discipline. Order visibility remains robust, with management targeting 70-75% capacity utilization in FY27. A ₹750 crore QIP was raised in July 2025 to fund expansion, and a ₹11.91 crore reversal of a labor liability improved Q4 profitability. Employee stock options were allotted in July 2026, signaling confidence in long-term incentives but introducing minor dilution.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue697491472502602524519606
Operating Profit206123121140123111119158
OPM %28.9%23.3%20.8%15.1%18.3%19.2%20.7%24.3%
Net Profit13662617870515984
EPS₹27.51₹12.41₹12.22₹15.74₹14.20₹10.33₹11.86₹16.86

Revenue and profitability have shown consistent improvement over the past four quarters, with Q4 FY26 marking the peak in OPM (18.3%) and NP growth (124% YoY). The upward trend in margins and volume growth aligns with management’s focus on high-margin specialty products and capacity additions. The ₹750 crore capital raise and project timelines indicate sustained investment in scalable infrastructure, supporting sustained top-line expansion despite macro cost pressures.

🔮 Management Outlook & What's Next

Management expressed confidence in FY27 performance, targeting 70-75% capacity utilization and sustained demand momentum in Specialty Chemicals and HPP segments. They highlighted successful pricing pass-through amid raw material inflation and maintained visibility into order books. No formal revenue or margin guidance was provided, but commentary on working capital stability and project execution suggests a constructive near-term outlook. The reappointment of Vishad P. Mafatlal as executive chairman for five years reinforces leadership continuity.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
Solar Industries India Limited 1.57 L Cr 132.3
Pidilite Industries Limited 1.49 L Cr 75.7
SRF Limited 79,723 69.5
Linde India Limited 62,701 141.9
Gujarat Fluorochemicals Limited 40,793 89.6
Navin Fluorine International Limited 35,894 131.5
Himadri Speciality Chemical Limited 30,071 56.6
Deepak Nitrite Limited 24,911 33.3
Atul Limited 20,904 48.8
Tata Chemicals Limited 19,079 -47.1

⚠️ Risk Factors

1. Execution delays in the Chemours and HFC projects could impact FY27 capacity targets and margin trajectory. 2. Raw material inflation may pressure margins if pricing power erodes. 3. High leverage from the ₹750 crore QIP may constrain flexibility if growth slows. 4. Labor law liability reversal in Q4 FY26 was non-recurring; absence of such tailwinds in future quarters could affect profitability.

📋 Recent Filings

🧠 Analyst's Read

Navin Fluorine is executing a clear expansion strategy with strong segmental growth and improving margins, but future performance hinges on timely project completion and sustained demand in specialty chemicals. Investors should monitor Capex progress, margin sustainability, and any guidance on FY27 profitability when assessing valuation.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NAVINFLUOR files new disclosures

Track NAVINFLUOR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NAVINFLUOR — Free

Free account · 2 AI queries/day